CLINICAL TRIALS
Biomobie Technology
[The Efficacy of BioBoosti 8 Minute Electromagnetic Cycles for the Treatment of Insomnia]

Medical Breakthrough with Biomobie Partner Harvard University

 

A study at Harvard University revealed that those 30-35% of the American population suffering insomnia now have a non-pharmaceutical option. Biomobie’s non-pharmaceutical, non-invasive, precision technology device has been demonstrated to relieve insomnia using revolutionary bioelectricity according to clinical trials conducted by Harvard University.

 

Massive Insomnia Problem and Health Risk

 

In February, 2016, the Centers for Disease Control and Prevention (CDC) published a press release notifying the public that fully 1 out of every 3 adults in the United States reported obtaining less than the recommended seven hours of nightly sleep on a regular basis. During the course of a given year, up to 40% of the adult population in the United States reports experiencing insomnia, with 60% of the people reporting insomnia suffering from some type of chronic health disorder. Over half of Americans aged 65 or older reported sleeping less than seven hours a night.

 

The World Health Organization studied insomnia (2004) and reported that insomnia has been statistically associated with various medical conditions, including disorders of the cardiovascular, respiratory, gastrointestinal, renal and musculoskeletal systems. A large study of insomniacs showed that poor sleepers are more than twice as much at risk of ischemic heart disease as good sleepers. Most individuals develop cognitive deficits from chronic sleep debt after only a few nights of reduced sleep quality or quantity; new evidence suggests additional important health-related consequences of sleep debt related to common viral illnesses, diabetes, obesity, heart disease, depression and other age-related chronic disorders.

哈佛大學治療失眠臨床醫學研究取得重大突破

 

哈佛大學臨床試驗證明,百慕迪發明的一種非藥物,非侵入性,創新性的生物電技術能有效緩解失眠癥狀。為占美國總人口 30-35%的失眠癥患者提供了一種新的非藥物治療手段。這一結果遠遠高于治療失眠的傳統藥物有效性。目前哈佛大學仍在繼續研究擴大臨床試驗人群并啟動了偏頭痛的臨床試驗。

 

大規模的失眠問題與健康風險

 

2016 年 2 月,美國疾病控制和預防中心(CDC)發布的一篇新聞稿稱,美國三分之一的成年人睡眠時間不足 7 小時。在某些年份內,失眠患者的比例甚至可高達 40%,其中 60%的失眠患者伴有慢性疾病。65 歲及以上的美國人中有超過一半睡眠時間少于 7 小時。

世界衛生組織研究報告(2004 年)稱,失眠問題與多種疾病具有統計學相關性,包括心血管疾病,呼吸系統疾病,胃腸疾病,腎臟疾病和肌肉骨骼系統疾病。一項關于失眠癥的大型研究表明,睡眠欠佳的人患缺血性心臟病的風險是睡眠良好者的 2 倍以上。大多數人即使僅僅幾天的睡眠質量或睡眠時長下降,也會引起注意力、學習力、記憶力等下降;新的研究證據表明睡眠障礙會導致其他很多重要健康問題,如病毒性疾病、糖尿病、肥胖癥、心臟病、抑郁癥和其他與年齡相關的慢性疾病等。

Harvard University
brigham & Women’S Hospital
John R. Graham Headache Center
百慕迪 (上海) 再生醫學科技有限公司

掃描二維碼分享到微信

大乐透开奖直播电视台是那个